What is the population of the EMPHASIS-HF study?
The population of the EMPHASIS-HF study was people aged 55 years with NYHA class II heart failure and LVEF 30% (or 35% if also QRS duration treatment with ACEI, ARB or both and a BB (unless contraindicated) at the recommended maximum dose. 87% on BB, 93% on ACEI and/or ARB. Patients were within 6 months of hospitalisation for CV reason (or high levels of BNP/NTpro-BNP).